BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22683513)

  • 1. Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice.
    Chatterjee M; Verma R; Ganguly S; Palit G
    Neuropharmacology; 2012 Nov; 63(6):1161-71. PubMed ID: 22683513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosis.
    Chatterjee M; Ganguly S; Srivastava M; Palit G
    Behav Brain Res; 2011 Jan; 216(1):247-54. PubMed ID: 20699106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fMRI).
    Yu H; Li Q; Wang D; Shi L; Lu G; Sun L; Wang L; Zhu W; Mak YT; Wong N; Wang Y; Pan F; Yew DT
    Neurotoxicology; 2012 Jan; 33(1):70-7. PubMed ID: 22178134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.
    Bubeníková-Valesová V; Horácek J; Vrajová M; Höschl C
    Neurosci Biobehav Rev; 2008 Jul; 32(5):1014-23. PubMed ID: 18471877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
    Large CH
    J Psychopharmacol; 2007 May; 21(3):283-301. PubMed ID: 17591656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic ingestion of uranyl nitrate perturbs acetylcholinesterase activity and monoamine metabolism in male rat brain.
    Bussy C; Lestaevel P; Dhieux B; Amourette C; Paquet F; Gourmelon P; Houpert P
    Neurotoxicology; 2006 Mar; 27(2):245-52. PubMed ID: 16325913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity.
    Becker A; Grecksch G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1267-77. PubMed ID: 15588753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of Troponin T1 gene is induced by ketamine in adult mouse brain.
    Lowe XR; Lu X; Marchetti F; Wyrobek AJ
    Brain Res; 2007 Oct; 1174():7-17. PubMed ID: 17850769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
    Dekeyne A; Brocco M; Loiseau F; Gobert A; Rivet JM; Di Cara B; Cremers TI; Flik G; Fone KC; Watson DJ; Papp M; Sharp T; Serres F; Cespuglio R; Olivier B; Chan JS; Lavielle G; Millan MJ
    J Pharmacol Exp Ther; 2012 Mar; 340(3):765-80. PubMed ID: 22178753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia.
    Mastropaolo J; Rosse RB; Deutsch SI
    Behav Brain Res; 2004 Aug; 153(2):419-22. PubMed ID: 15265637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurokinin-1 receptor deletion modulates behavioural and neurochemical alterations in an animal model of depression.
    Roche M; Kerr DM; Hunt SP; Kelly JP
    Behav Brain Res; 2012 Mar; 228(1):91-8. PubMed ID: 22155476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
    Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
    Heekeren K; Neukirch A; Daumann J; Stoll M; Obradovic M; Kovar KA; Geyer MA; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2007 May; 21(3):312-20. PubMed ID: 17591658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine administration induces early and persistent neurochemical imbalance and altered NADPH oxidase in mice.
    Schiavone S; Morgese MG; Bove M; Colia AL; Maffione AB; Tucci P; Trabace L; Cuomo V
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109750. PubMed ID: 31446158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 fatty acids prevent the ketamine-induced increase in acetylcholinesterase activity in an animal model of schizophrenia.
    Zugno AI; Chipindo H; Canever L; Budni J; Alves de Castro A; Bittencourt de Oliveira M; Heylmann AS; Gomes Wessler P; da Rosa Silveira F; Damázio LS; Mastella GA; Kist LW; Bogo MR; Quevedo J; Gama CS
    Life Sci; 2015 Jan; 121():65-9. PubMed ID: 25498892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas.
    Perry KW; Falcone JF; Fell MJ; Ryder JW; Yu H; Love PL; Katner J; Gordon KD; Wade MR; Man T; Nomikos GG; Phebus LA; Cauvin AJ; Johnson KW; Jones CK; Hoffmann BJ; Sandusky GE; Walter MW; Porter WJ; Yang L; Merchant KM; Shannon HE; Svensson KA
    Neuropharmacology; 2008 Oct; 55(5):743-54. PubMed ID: 18602930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subchronic administration of ketamine decreases the mRNA expression of serine racemase in rat brain.
    Watanabe M; Yoshikawa M; Takeyama K; Hashimoto A; Kobayashi H; Suzuki T
    Tokai J Exp Clin Med; 2010 Dec; 35(4):137-43. PubMed ID: 21319044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.